Wasik MA - Search Results

1

Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins.

Woetmann A, Lovato P, Eriksen KW, Krejsgaard T, Labuda T, Zhang Q, Mathiesen AM, Geisler C, Svejgaard A, Wasik MA, Ødum N. Woetmann A, et al. Among authors: wasik ma. Blood. 2007 Apr 15;109(8):3325-32. doi: 10.1182/blood-2006-04-017863. Epub 2006 Dec 19. Blood. 2007. PMID: 17179233 Free PMC article.

2

Cutaneous CD56+ large T-cell lymphoma associated with high serum concentration of IL-2.

Wasik MA, Sackstein R, Novick D, Butmarc JR, Zhang Q, Vonderheid EC, Kadin ME. Wasik MA, et al. Hum Pathol. 1996 Jul;27(7):738-44. doi: 10.1016/s0046-8177(96)90408-6. Hum Pathol. 1996. PMID: 8698322 Free article.

3

Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma.

Vonderheid EC, Zhang Q, Lessin SR, Polansky M, Abrams JT, Bigler RD, Wasik MA. Vonderheid EC, et al. Among authors: wasik ma. J Am Acad Dermatol. 1998 Feb;38(2 Pt 1):207-20. doi: 10.1016/s0190-9622(98)70597-3. J Am Acad Dermatol. 1998. PMID: 9486676

4

Suppression of proliferation and phosphorylation of Jak3 and STAT5 in malignant T-cell lymphoma cells by derivatives of octylamino-undecyl-dimethylxanthine.

Wasik MA, Nowak I, Zhang Q, Shaw LM. Wasik MA, et al. Leuk Lymphoma. 1998 Feb;28(5-6):551-60. doi: 10.3109/10428199809058363. Leuk Lymphoma. 1998. PMID: 9613985

5

Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter.

Zhang Q, Raghunath PN, Vonderheid E, Odum N, Wasik MA. Zhang Q, et al. Among authors: wasik ma. Am J Pathol. 2000 Oct;157(4):1137-46. doi: 10.1016/S0002-9440(10)64629-9. Am J Pathol. 2000. PMID: 11021818 Free PMC article.

6

STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma.

Brender C, Nielsen M, Kaltoft K, Mikkelsen G, Zhang Q, Wasik M, Billestrup N, Odum N. Brender C, et al. Blood. 2001 Feb 15;97(4):1056-62. doi: 10.1182/blood.v97.4.1056. Blood. 2001. PMID: 11159537 Free article.

7

Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells.

Eriksen KW, Kaltoft K, Mikkelsen G, Nielsen M, Zhang Q, Geisler C, Nissen MH, Röpke C, Wasik MA, Odum N. Eriksen KW, et al. Among authors: wasik ma. Leukemia. 2001 May;15(5):787-93. doi: 10.1038/sj.leu.2402093. Leukemia. 2001. PMID: 11368440

8

Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma.

Zhang Q, Raghunath PN, Xue L, Majewski M, Carpentieri DF, Odum N, Morris S, Skorski T, Wasik MA. Zhang Q, et al. Among authors: wasik ma. J Immunol. 2002 Jan 1;168(1):466-74. doi: 10.4049/jimmunol.168.1.466. J Immunol. 2002. PMID: 11751994

9

SHP2 regulates IL-2 induced MAPK activation, but not Stat3 or Stat5 tyrosine phosphorylation, in cutaneous T cell lymphoma cells.

Lundin Brockdorff J, Woetmann A, Mustelin T, Kaltoft K, Zhang Q, Wasik MA, Röpke C, Ødum N. Lundin Brockdorff J, et al. Among authors: wasik ma. Cytokine. 2002 Nov 24;20(4):141-7. doi: 10.1006/cyto.2002.1986. Cytokine. 2002. PMID: 12543077

10

In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3.

Sommer VH, Clemmensen OJ, Nielsen O, Wasik M, Lovato P, Brender C, Eriksen KW, Woetmann A, Kaestel CG, Nissen MH, Ropke C, Skov S, Ødum N. Sommer VH, et al. Leukemia. 2004 Jul;18(7):1288-95. doi: 10.1038/sj.leu.2403385. Leukemia. 2004. PMID: 15141228

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters